IDENIX PHARMACEUTICALS INC's ticker is IDIX and the CUSIP is 45166R204. A total of 98 filers reported holding IDENIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $1,269,560,000 | +319.2% | 53,331,109 | 0.0% | 20.68% | +182.4% |
| Q1 2014 | $302,844,000 | +37.2% | 53,331,109 | +44.5% | 7.32% | +17.0% |
| Q4 2013 | $220,727,000 | +43.4% | 36,910,868 | +24.4% | 6.25% | +42.1% |
| Q3 2013 | $153,965,000 | +59.3% | 29,665,693 | +10.8% | 4.40% | +83.1% |
| Q2 2013 | $96,629,000 | – | 26,767,000 | – | 2.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 26,767,000 | $96,629,000 | 2.40% |
| Bain Capital Public Equity Management, LLC | 12,664,950 | $45,720,000 | 1.07% |
| Camber Capital Management LP | 2,750,000 | $9,927,000 | 1.02% |
| BRIDGER MANAGEMENT, LLC | 3,260,628 | $11,771,000 | 0.86% |
| BB BIOTECH AG | 1,250,000 | $4,513,000 | 0.32% |
| GENERAL AMERICAN INVESTORS CO INC | 858,979 | $3,101,000 | 0.28% |
| Aris Wealth Services, Inc. | 30,000 | $108,000 | 0.23% |
| AlpInvest Partners B.V. | 56,986 | $206,000 | 0.20% |
| Visium Asset Management, LP | 1,350,000 | $4,874,000 | 0.11% |
| Old West Investment Management, LLC | 57,949 | $209,000 | 0.10% |